These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 21555309)

  • 1. High-sensitivity C-reactive protein is a predictor of in-hospital cardiac events in acute myocardial infarction independently of GRACE risk score.
    Raposeiras-Roubín S; Barreiro Pardal C; Rodiño Janeiro B; Abu-Assi E; García-Acuña JM; González-Juanatey JR
    Angiology; 2012 Jan; 63(1):30-4. PubMed ID: 21555309
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does high-sensitivity C-reactive protein add prognostic value to the TIMI-Risk Score in individuals with non-ST elevation acute coronary syndromes?
    Correia LC; Lima JC; Rocha MS; D'Oliveira Junior A; Péricles Esteves J
    Clin Chim Acta; 2007 Jan; 375(1-2):124-8. PubMed ID: 16916502
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-sensitivity C-reactive protein predicts adverse outcomes after non-ST-segment elevation acute coronary syndrome regardless of GRACE risk score, but not after ST-segment elevation myocardial infarction.
    Raposeiras Roubín S; Barreiro Pardal C; Roubín-Camiña F; Ocaranza Sanchez R; Alvarez Castro E; Paradela Dobarro B; García-Acuña JM; Aguiar Souto P; Jacquet Hervet M; Castromán MJ; Arufe I; Outes B; Reino-Maceiras MV; Abu Assi E; González-Juanatey JR
    Rev Port Cardiol; 2013 Feb; 32(2):117-22. PubMed ID: 23337430
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Diagnostic and prognostic value of atherosclerosis risk factors for predicting 1 year outcome in patients with acute myocardial infarction and in patients with stable coronary artery disease receiving percutaneous transluminal coronary angioplasty].
    Drobniak-Hełdak D; Kolasińska-Kloch W; Rajtar-Salwa R
    Folia Med Cracov; 2009; 50(3-4):43-54. PubMed ID: 21853870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of usefulness of N-terminal pro-brain natriuretic peptide as an independent predictor of cardiac function among admission cardiac serum biomarkers in patients with anterior wall versus nonanterior wall ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Haeck JD; Verouden NJ; Kuijt WJ; Koch KT; Van Straalen JP; Fischer J; Groenink M; Bilodeau L; Tijssen JG; Krucoff MW; De Winter RJ
    Am J Cardiol; 2010 Apr; 105(8):1065-9. PubMed ID: 20381654
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hospital discharge risk score system for the assessment of clinical outcomes in patients with acute myocardial infarction (Korea Acute Myocardial Infarction Registry [KAMIR] score).
    Kim HK; Jeong MH; Ahn Y; Kim JH; Chae SC; Kim YJ; Hur SH; Seong IW; Hong TJ; Choi DH; Cho MC; Kim CJ; Seung KB; Chung WS; Jang YS; Rha SW; Bae JH; Cho JG; Park SJ;
    Am J Cardiol; 2011 Apr; 107(7):965-971.e1. PubMed ID: 21256468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The pro- and anti-inflammatory markers in patients with acute myocardial infarction and chronic stable angina.
    Wojakowski W; Maslankiewicz K; Ochala A; Wyderka R; Zuk-Popiolek I; Flak Z; Mroz I; Tendera M
    Int J Mol Med; 2004 Aug; 14(2):317-22. PubMed ID: 15254785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic role of post-infarction C-reactive protein in patients undergoing implantation of cardioverter-defibrillators: design of the C-reactive protein Assessment after Myocardial Infarction to GUide Implantation of DEfibrillator (CAMI GUIDE) study.
    Bellocci F; Biasucci LM; Gensini GF; Padeletti L; Raviele A; Santini M; Giubilato G; Landolina M; Biondi-Zoccai G; Raciti G; Sassara M; Castro A; Kheir A; Crea F
    J Cardiovasc Med (Hagerstown); 2007 Apr; 8(4):293-9. PubMed ID: 17413310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Significance of acute-phase inflammatory reactants as an indicator of prognosis after acute myocardial infarction: which is the most useful predictor?].
    Katayama T; Nakashima H; Yonekura T; Honda Y; Suzuki S; Yano K
    J Cardiol; 2003 Aug; 42(2):49-56. PubMed ID: 12964514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Evaluation of dynamic cardiac troponin I concentrations and C-reactive protein in the monitoring of myocardial infarction in patients with repeated myocardial infarction].
    Plak M; Orliński L; Łobos M; Ciesielczyk M; Wlazeł RN; Paradowski MT
    Pol Merkur Lekarski; 2010 Jun; 28(168):444-9. PubMed ID: 20642101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. C-terminal provasopressin (copeptin) as a prognostic marker after acute non-ST elevation myocardial infarction: Leicester Acute Myocardial Infarction Peptide II (LAMP II) study.
    Narayan H; Dhillon OS; Quinn PA; Struck J; Squire IB; Davies JE; Ng LL
    Clin Sci (Lond); 2011 Jul; 121(2):79-89. PubMed ID: 21309746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Independent prognostic value of elevated high-sensitivity C-reactive protein in chronic heart failure.
    Yin WH; Chen JW; Jen HL; Chiang MC; Huang WP; Feng AN; Young MS; Lin SJ
    Am Heart J; 2004 May; 147(5):931-8. PubMed ID: 15131554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. C-reactive protein in acute myocardial infarction: association with heart failure.
    Berton G; Cordiano R; Palmieri R; Pianca S; Pagliara V; Palatini P
    Am Heart J; 2003 Jun; 145(6):1094-101. PubMed ID: 12796768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prognostic value of C-reactive protein and troponin T level in patients with unstable angina pectoris].
    Tanaka H; Tsurumi Y; Kasanuki H
    J Cardiol; 2006 Apr; 47(4):173-9. PubMed ID: 16637251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Usefulness of plasma tissue inhibitors of metalloproteinases as markers of prognosis after acute myocardial infarction.
    Kelly D; Squire IB; Khan SQ; Dhillon O; Narayan H; Ng KH; Quinn P; Davies JE; Ng LL
    Am J Cardiol; 2010 Aug; 106(4):477-82. PubMed ID: 20691304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Routinely-feasible multiple biomarkers score to predict prognosis after revascularized STEMI.
    Roubille F; Samri A; Cornillet L; Sportouch-Dukhan C; Davy JM; Raczka F; Gervasoni R; Pasquie JL; Cung TT; Piot C; Macia JC; Cransac F; Leclercq F
    Eur J Intern Med; 2010 Apr; 21(2):131-6. PubMed ID: 20206886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-sensitivity C-reactive protein and left ventricular remodeling in patients with acute myocardial infarction.
    Uehara K; Nomura M; Ozaki Y; Fujinaga H; Ikefuji H; Kimura M; Chikamori K; Nakaya Y; Ito S
    Heart Vessels; 2003 May; 18(2):67-74. PubMed ID: 12756602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic usefulness of serial C-reactive protein measurements in ST-elevation acute myocardial infarction.
    Makrygiannis SS; Ampartzidou OS; Zairis MN; Patsourakos NG; Pitsavos C; Tousoulis D; Prekates AA; Foussas SG; Cokkinos DV
    Am J Cardiol; 2013 Jan; 111(1):26-30. PubMed ID: 23040593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of high-sensitivity C-reactive protein in patients with chronic heart failure.
    Xue C; Feng Y; Wo J; Li Y
    N Z Med J; 2006 Nov; 119(1245):U2314. PubMed ID: 17146489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improving long-term risk prediction in patients with acute chest pain: the Global Registry of Acute Coronary Events (GRACE) risk score is enhanced by selected nonnecrosis biomarkers.
    Eggers KM; Kempf T; Venge P; Wallentin L; Wollert KC; Lindahl B
    Am Heart J; 2010 Jul; 160(1):88-94. PubMed ID: 20598977
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.